Predicting vascular complications in percutaneous coronary interventions - 28/08/11
, David J Malenka, MD, FACC b, Thomas J Ryan, MD, FACC c, Samuel J Shubrooks, MD, FACC d, Gerald T O’Connor, PhD, DSc a, e, John F Robb, MD, FACC b, Karen L Farrell, ANP, MSN f, Mary S Corliss, RN, BSN, CCRN g, Michael J Hearne, MD, FACC h, Mirle A Kellett, MD, FACC c, Matthew W Watkins, MD, FACC f, William A Bradley, MD, FACC h, Bruce D Hettleman, MD, FACC b, Theodore M Silver, MD, FACC i, Paul D McGrath, MD, MS, FACC j, John R O’Mears, MD, FACC c, David E Wennberg, MD, MPH jNorthern New England Cardiovascular Disease Study Group
Abstract |
Objectives |
Using a large, current, regional registry of percutaneous coronary interventions (PCI), we identified risk factors for postprocedure vascular complications and developed a scoring system to estimate individual patient risk.
Background |
A vascular complication (access-site injury requiring treatment or bleeding requiring transfusion) is a potentially avoidable outcome of PCI.
Methods |
Data were collected on 18,137 consecutive patients undergoing PCI in northern New England from January 1997 to December 1999. Multivariate regression was used to identify characteristics associated with vascular complications and to develop a scoring system to predict risk.
Results |
The rate of vascular complication was 2.98% (541 cases). Variables associated with increased risk in the multivariate analysis included age ≥70, odds ratio (OR) 2.7, female sex (OR 2.4), body surface area <1.6 m2 (OR 1.9), history of congestive heart failure (OR 1.4), chronic obstructive pulmonary disease (OR 1.5), renal failure (OR 1.9), lower extremity vascular disease (OR 1.4), bleeding disorder (OR 1.68), emergent priority (OR 2.3), myocardial infarction (OR 1.7), shock (1.86), ≥1 type B2 (OR 1.32) or type C (OR 1.7) lesions, 3-vessel PCI (OR 1.5), use of thienopyridines (OR 1.4) or use of glycoprotein IIb/IIIa receptor inhibitors (OR 1.9). The model performed well in tests for significance, discrimination, and calibration. The scoring system captured 75% of actual vascular complications in its highest quintiles of predicted risk.
Conclusion |
Predicting the risk of post-PCI vascular complications is feasible. This information may be useful for clinical decision-making and institutional efforts at quality improvement.
Le texte complet de cet article est disponible en PDF.Plan
Vol 145 - N° 6
P. 1022-1029 - juin 2003 Retour au numéro
Article précédent
- Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus
- Peter Mazeika, Neeraj Prasad, Sanh Bui, Peter H Seidelin
- Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: Secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) study
- Bjørn Jørgensen, Erik Thaulow, CAPARES trial
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?